2016
DOI: 10.1080/21691401.2016.1246452
|View full text |Cite
|
Sign up to set email alerts
|

An overview on different strategies for the stemness maintenance of MSCs

Abstract: Recent evidence suggests that mesenchymal stem cells (MSCs) have promising therapeutic potential for a broad range of diseases. Because the percentage of MSCs obtained from tissues is very low for cell therapy applications, ex vivo expansion of MSCs is necessary, but aging, loss of stemness and undesired differentiation of them during in vitro cultivation reduces their effectiveness. For achieving ideal therapeutic potential of MSCs in tissue regenerative purposes, it is necessary to retain their stemness prop… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
36
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
9
1

Relationship

2
8

Authors

Journals

citations
Cited by 54 publications
(36 citation statements)
references
References 120 publications
0
36
0
Order By: Relevance
“…These results demonstrate that EO-PCL/PEG nanofibres have high biocompatibility compared with PCL/PEG nanofibres. Also, using co-polymerized PCL with PEG has provided highly biocompatible, hydrophilic, non-toxic, non-immunogenic, and non-antigenic nanofibres [22,23]. The high viabilities of macrophages on EO-PCL/PEG nanofibres partially reflects biocompatibility of the composite biomaterials and can be benefit for wound healing process and implant survival.…”
Section: Macrophage Viabilitymentioning
confidence: 99%
“…These results demonstrate that EO-PCL/PEG nanofibres have high biocompatibility compared with PCL/PEG nanofibres. Also, using co-polymerized PCL with PEG has provided highly biocompatible, hydrophilic, non-toxic, non-immunogenic, and non-antigenic nanofibres [22,23]. The high viabilities of macrophages on EO-PCL/PEG nanofibres partially reflects biocompatibility of the composite biomaterials and can be benefit for wound healing process and implant survival.…”
Section: Macrophage Viabilitymentioning
confidence: 99%
“…Type I diabetes is caused by the autoimmune destruction of beta cells in pancreatic islets. While replacing pancreatic beta cells would be an ideal therapy [24,25], generation of beta cells from stem or other cells is an attractive alternative [26][27][28]. In pancreatic islets, only a small subset of cells expresses nestin, and these have been proposed to be precursors of differentiated pancreatic endocrine cells [13].…”
Section: Discussionmentioning
confidence: 99%
“…Regarding the self‐renewal activity and plasticity extension of stem cells to several lineages, the elucidation of both in vivo and in vitro factors controlling multipotential properties is required to improve the basic knowledge of stem cells biology for providing large enough quantity of cells and further therapeutic manipulation (Saei Arezoumand et al ., ; Dadashpour et al ., ).…”
Section: Stem Cells Characteristics At a Glancementioning
confidence: 99%